These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Synthesis and biological activities of 1-pyridylisoquinoline and 1-pyridyldihydroisoquinoline derivatives as PDE4 inhibitors. Ukita T; Sugahara M; Terakawa Y; Kuroda T; Wada K; Nakata A; Kikkawa H; Ikezawa K; Naito K Bioorg Med Chem Lett; 2003 Jul; 13(14):2347-50. PubMed ID: 12824031 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of a novel series of phosphodiesterase IV inhibitors. A potential treatment for asthma. Beasley SC; Cooper N; Gowers L; Gregory JP; Haughan AF; Hellewell PG; Macari D; Miotla J; Montana JG; Morgan T; Naylor R; Runcie KA; Tuladhar B; Warneck JB Bioorg Med Chem Lett; 1998 Oct; 8(19):2629-34. PubMed ID: 9873593 [TBL] [Abstract][Full Text] [Related]
12. The synthesis and biological evaluation of a novel series of indole PDE4 inhibitors I. Hulme C; Moriarty K; Miller B; Mathew R; Ramanjulu M; Cox P; Souness J; Page KM; Uhl J; Travis J; Huang FC; Labaudiniere R; Djuric SW Bioorg Med Chem Lett; 1998 Jul; 8(14):1867-72. PubMed ID: 9873449 [TBL] [Abstract][Full Text] [Related]
13. Discovery of a substituted 8-arylquinoline series of PDE4 inhibitors: structure-activity relationship, optimization, and identification of a highly potent, well tolerated, PDE4 inhibitor. Macdonald D; Mastracchio A; Perrier H; Dubé D; Gallant M; Lacombe P; Deschênes D; Roy B; Scheigetz J; Bateman K; Li C; Trimble LA; Day S; Chauret N; Nicoll-Griffith DA; Silva JM; Huang Z; Laliberté F; Liu S; Ethier D; Pon D; Muise E; Boulet L; Chan CC; Styhler A; Charleson S; Mancini J; Masson P; Claveau D; Nicholson D; Turner M; Young RN; Girard Y Bioorg Med Chem Lett; 2005 Dec; 15(23):5241-6. PubMed ID: 16168647 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, structure-activity relationships, and pharmacological profile of 9-amino-4-oxo-1-phenyl-3,4,6,7-tetrahydro[1,4]diazepino[6, 7,1-hi]indoles: discovery of potent, selective phosphodiesterase type 4 inhibitors. Burnouf C; Auclair E; Avenel N; Bertin B; Bigot C; Calvet A; Chan K; Durand C; Fasquelle V; Féru F; Gilbertsen R; Jacobelli H; Kebsi A; Lallier E; Maignel J; Martin B; Milano S; Ouagued M; Pascal Y; Pruniaux MP; Puaud J; Rocher MN; Terrasse C; Wrigglesworth R; Doherty AM J Med Chem; 2000 Dec; 43(25):4850-67. PubMed ID: 11123995 [TBL] [Abstract][Full Text] [Related]
15. Substituted 2-pyridinemethanol derivatives as potent and selective phosphodiesterase-4 inhibitors. Ducharme Y; Friesen RW; Blouin M; Côté B; Dubé D; Ethier D; Frenette R; Laliberté F; Mancini JA; Masson P; Styhler A; Young RN; Girard Y Bioorg Med Chem Lett; 2003 Jun; 13(11):1923-6. PubMed ID: 12749899 [TBL] [Abstract][Full Text] [Related]
16. Quaternary substituted PDE4 inhibitors I: the synthesis and in vitro evaluation of a novel series of oxindoles. Hulme C; Poli GB; Huang FC; Souness JE; Djuric SW Bioorg Med Chem Lett; 1998 Jan; 8(2):175-8. PubMed ID: 9871649 [TBL] [Abstract][Full Text] [Related]
17. The synthesis and biological evaluation of a novel series of phthalazine PDE4 inhibitors I. Napoletano M; Norcini G; Pellacini F; Marchini F; Morazzoni G; Ferlenga P; Pradella L Bioorg Med Chem Lett; 2000 Oct; 10(19):2235-8. PubMed ID: 11012037 [TBL] [Abstract][Full Text] [Related]
18. Substituted 4-(2,2-diphenylethyl)pyridine-N-oxides as phosphodiesterase-4 inhibitors: SAR study directed toward the improvement of pharmacokinetic parameters. Frenette R; Blouin M; Brideau C; Chauret N; Ducharme Y; Friesen RW; Hamel P; Jones TR; Laliberté F; Li C; Masson P; McAuliffe M; Girard Y Bioorg Med Chem Lett; 2002 Oct; 12(20):3009-13. PubMed ID: 12270195 [TBL] [Abstract][Full Text] [Related]
19. 2-Substituted-4-methoxybenzimidazole-based PDE4 inhibitors. Regan J; Bruno J; McGarry D; Poli G; Hanney B; Bower S; Travis J; Sweeney D; Miller B; Souness J; Djuric S Bioorg Med Chem Lett; 1998 Oct; 8(19):2737-42. PubMed ID: 9873613 [TBL] [Abstract][Full Text] [Related]